Biogen $18.9 Million Securities Class Action Settlement

Biogen $18.9 Million Securities Class Action Settlement

See details
Max Payout
Sep 24, 2026
Filing Deadline
Yes
Proof Required?
Biogen, the biotechnology company, is facing an $18.9 million securities class action settlement. Securities class action lawsuits like this one are typically brought on behalf of investors who purchased shares during a specific period and allegedly suffered losses due to misleading statements or omissions that affected the stock price. If you bought Biogen stock during the relevant class period, you may be entitled to a share of this settlement fund. This type of case is common in the pharmaceutical and biotech space, where news about drug approvals, clinical trial results, or regulatory decisions can cause dramatic swings in stock value. Investors who bought shares at inflated prices and later sold at a loss may have a valid claim. The settlement does not require Biogen to admit any wrongdoing — it is a resolution agreed to by both sides to avoid the cost and uncertainty of a trial. The $18.9 million fund will be distributed among eligible claimants after legal fees and administrative costs are deducted.
🎯

Not sure if this settlement applies to you?

Take our 60-second eligibility quiz to find every settlement you qualify for — including this one.

Check Eligibility →

Who Is Eligible?

You may be eligible to file a claim if you:

  • You purchased or acquired Biogen securities (such as common stock) during the class period defined in the settlement
  • You suffered a financial loss as a result of holding or selling those securities
  • You are a U.S.-based or international investor who held a qualifying position in Biogen stock during the relevant timeframe
  • Institutional investors, individual retail investors, and retirement accounts may all qualify — check your brokerage records
  • You did not opt out of the class action prior to the settlement

How Much Can You Get?

The total settlement fund is $18.9 million. Your individual payout will depend on how many valid claims are submitted and the size of your recognized loss — meaning how many shares you bought, at what price, and what losses you incurred during the class period. Investors with larger positions who suffered greater losses will generally receive a higher proportion of the settlement fund. Specific per-share payment amounts are not yet publicly confirmed, so the final payout per claimant remains to be determined once all claims are reviewed. Historically, securities settlements of this size can result in payouts ranging from a few dollars to hundreds of dollars per claimant, depending on claim volume and individual loss calculations. Filing a claim is worth doing even if your expected recovery seems modest.

How to File Your Claim

Filing your claim is quick and easy:

  • Confirm you purchased Biogen securities during the applicable class period by reviewing your brokerage or investment account statements
  • Gather documentation of your trades, including purchase dates, number of shares, purchase price, and any sale transactions — this proof is required
  • Visit the official settlement claims administrator website to obtain the claim form (check ClassActionBuddy or the settlement URL for the latest link)
  • Complete the claim form accurately, including all required trade information and your contact details
  • Submit your claim form along with supporting documentation before the deadline of September 24, 2026
  • Download the Class Action Buddy app to track your claim status, get deadline reminders, and discover other settlements you may qualify for

💡 Easier way: File with Class Action Buddy

Skip the paperwork. Our app auto-fills your claim form with your saved profile and submits it electronically in under 2 minutes.

Download for iPhone Download for Android

Frequently Asked Questions

What is the deadline to file a claim for the Biogen $18.9 Million Securities Class Action Settlement?

The current deadline to file a claim is Sep 24, 2026. Note: claims sent by mail must be postmarked by this date, and Class Action Buddy ships claim forms with a 7-day mailing buffer to ensure on-time delivery.

Do I need proof of purchase for the Biogen $18.9 Million Securities Class Action Settlement?

Yes — this settlement requires proof of purchase. Acceptable proof typically includes receipts, credit card statements, photos of the product, or order confirmation emails. Check the official claim form for specifics.

How do I file a claim for the Biogen $18.9 Million Securities Class Action Settlement?

You have two options: (1) Use the free Class Action Buddy mobile app — set up your profile once and the app auto-fills the PDF claim form, captures your signature, and submits the claim by mail on your behalf. (2) File directly with the settlement administrator using the official claim form linked on this page.

Who qualifies for the Biogen securities class action settlement?

Investors who purchased Biogen securities during the defined class period and suffered financial losses may qualify. You'll need brokerage records showing your trades to file a valid claim.

How much money will I get from the Biogen settlement?

Your payout depends on the size of your recognized loss and the total number of valid claims filed. The total fund is $18.9 million, and individual payouts vary. Larger losses generally result in a higher payment.

What is the deadline to file a Biogen securities settlement claim?

The claim filing deadline is September 24, 2026. Make sure to submit your completed claim form with all required documentation before this date to be eligible for a payment.

Do I need proof to file a Biogen securities settlement claim?

Yes, proof is required. You'll need to provide documentation of your Biogen stock transactions, such as brokerage statements or trade confirmations showing purchase and sale dates, share quantities, and prices.

Is the Biogen securities settlement legitimate?

Yes, this is a legitimate $18.9 million class action settlement. Securities class actions are filed on behalf of investors and overseen by a federal court. Biogen has agreed to this settlement without admitting wrongdoing.

Ready to File Your Claim?

We're adding new settlements regularly. Download the app to get notified when this one is available.

Download Class Action Buddy →